Technical Description
The present invention relates to the heterocyclic substituted dicarbonyl compound. It introduces piperazine, piperidine, and indole-substituted α-ketoamides as amyloid-beta aggregation modulators, promoting stable fibril formation and slowing aggregation kinetics.
Problems Addressed
- Alzheimer’s Disease Treatment Gap
- Complex Process
- Rising Neurological Disorders
- Complicated Structure
Tech Features
- Novel Compound
- Chemo-Selective Reduction
- Flexible Structure
- Optimized Reaction
- High Therapeutic Potential
- Improved Efficacy
- Amyloid-beta Aggregation Modulator
Target Audience
- Medical and Healthcare Sector
- Drug formulation Industry
- Pharmaceuticals Industry
- Research & Development
Tech ID: P27-1379 TRL 4 Patent Status: Granted Available For Exclusive and Non-exclusive License
